China Traditional Chinese Medicine Holdings Co. Limited
HKEX:0570.HK
4.33 (HKD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 18,121.861 | 14,304.242 | 19,052.802 | 14,806.168 | 14,320.949 | 11,258.941 | 8,337.795 | 6,532.867 | 3,709.406 | 2,690.173 | 1,394.613 | 1,021.1 | 822.225 | 800.391 | 590.055 | 390.533 | 333.387 | 109.923 | 857.771 | 789.166 | 763.939 | 777.283 | 837.682 | 851.494 | 843.28 |
| Cost of Revenue
| 8,847.369 | 7,105.79 | 7,223.639 | 5,680.093 | 5,745.161 | 5,065.368 | 3,686.213 | 2,745.187 | 1,515.453 | 1,035.85 | 568.834 | 462.918 | 378.384 | 353.907 | 305.938 | 251.163 | 216.758 | 67.338 | 964.017 | 796.654 | 681.684 | 575.483 | 696.407 | 753.563 | 567.82 |
| Gross Profit
| 9,274.492 | 7,198.452 | 11,829.163 | 9,126.075 | 8,575.788 | 6,193.573 | 4,651.582 | 3,787.68 | 2,193.953 | 1,654.323 | 825.779 | 558.183 | 443.84 | 446.484 | 284.117 | 139.37 | 116.629 | 42.585 | -106.246 | -7.489 | 82.255 | 201.8 | 141.275 | 97.931 | 275.46 |
| Gross Profit Ratio
| 0.512 | 0.503 | 0.621 | 0.616 | 0.599 | 0.55 | 0.558 | 0.58 | 0.591 | 0.615 | 0.592 | 0.547 | 0.54 | 0.558 | 0.482 | 0.357 | 0.35 | 0.387 | -0.124 | -0.009 | 0.108 | 0.26 | 0.169 | 0.115 | 0.327 |
| Reseach & Development Expenses
| 685.632 | 611.831 | 694.441 | 550.472 | 463.996 | 346.539 | 202.16 | 186.832 | 112.324 | 67.875 | 45.947 | 34.512 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 1,043.318 | 944.404 | 974.449 | 707.278 | 686.189 | 552.294 | 349.449 | 329.986 | 269.986 | 217.022 | 167.745 | 113.515 | 105.659 | 93.799 | 69.091 | 37.197 | 35.254 | 20.935 | 25.456 | 23.995 | 24.003 | 30.7 | 19.418 | 13.18 | 21.794 |
| Selling & Marketing Expenses
| 6,403.201 | 4,604.098 | 7,581.963 | 5,586.737 | 5,109.153 | 3,417.195 | 2,437.167 | 1,968.432 | 1,195.636 | 903.493 | 404.629 | 233.225 | 265.979 | 270.293 | 142.303 | 58.322 | 52.446 | 23.276 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 7,446.519 | 5,548.502 | 8,556.412 | 5,586.737 | 5,109.153 | 3,417.195 | 2,786.616 | 2,298.418 | 1,195.636 | 903.493 | 404.629 | 233.225 | 371.638 | 364.092 | 211.394 | 95.519 | 87.699 | 44.211 | 25.456 | 23.995 | 24.003 | 30.7 | 19.418 | 13.18 | 21.794 |
| Other Expenses
| -0.432 | -152.251 | -127.971 | 510.211 | 564.861 | 36.191 | -5.727 | -4.101 | -3.831 | 0.244 | -1.364 | 0.557 | -10.465 | -19.074 | -11.611 | -4.386 | 0 | 0 | 727.261 | 18.624 | 37.845 | 29.456 | 30.394 | 33.52 | 33.664 |
| Operating Expenses
| 7,915.24 | 6,008.082 | 9,122.882 | 6,647.42 | 6,138.01 | 4,220.475 | 2,925.925 | 2,418.357 | 1,547.795 | 1,108.122 | 569.547 | 345.884 | 361.172 | 345.017 | 199.783 | 91.133 | 87.699 | 44.211 | 752.718 | 42.619 | 61.847 | 60.156 | 49.812 | 46.699 | 55.458 |
| Operating Income
| 1,427.277 | 1,064.283 | 2,753.058 | 2,490.631 | 2,460.716 | 2,156.025 | 1,786.453 | 1,435.243 | 755.748 | 545.39 | 272.757 | 233.357 | 82.668 | 101.467 | 84.335 | 48.237 | 32.005 | 0.478 | -839.83 | -50.108 | 20.408 | 141.644 | 91.463 | 59.214 | 234.613 |
| Operating Income Ratio
| 0.079 | 0.074 | 0.144 | 0.168 | 0.172 | 0.191 | 0.214 | 0.22 | 0.204 | 0.203 | 0.196 | 0.229 | 0.101 | 0.127 | 0.143 | 0.124 | 0.096 | 0.004 | -0.979 | -0.063 | 0.027 | 0.182 | 0.109 | 0.07 | 0.278 |
| Total Other Income Expenses Net
| -124.136 | -224.174 | -232.778 | -260.54 | -306.098 | -299.328 | -219.216 | -131.439 | 13.622 | -64.217 | -35.182 | -19.189 | -6.223 | -3.265 | -4.685 | -1.213 | -1.178 | -4.271 | -19.315 | -22.258 | -28.187 | -36.764 | -49.958 | -73.064 | -83.937 |
| Income Before Tax
| 1,224.533 | 840.109 | 2,520.28 | 2,230.091 | 2,154.618 | 1,856.697 | 1,567.237 | 1,303.804 | 769.37 | 481.173 | 237.575 | 214.169 | 76.445 | 98.202 | 79.65 | 47.023 | 30.826 | -5.897 | -859.145 | -72.366 | -7.779 | 104.88 | 41.504 | -13.849 | 150.676 |
| Income Before Tax Ratio
| 0.068 | 0.059 | 0.132 | 0.151 | 0.15 | 0.165 | 0.188 | 0.2 | 0.207 | 0.179 | 0.17 | 0.21 | 0.093 | 0.123 | 0.135 | 0.12 | 0.092 | -0.054 | -1.002 | -0.092 | -0.01 | 0.135 | 0.05 | -0.016 | 0.179 |
| Income Tax Expense
| -171.537 | 119.357 | 396.856 | 369.447 | 381.321 | 289.669 | 255.804 | 217.264 | 118.328 | 69.627 | 38.218 | 42.941 | 16.791 | 24.843 | 19.58 | 4.348 | 7.374 | 0.511 | -18.94 | -7.94 | 5.737 | 29.21 | 14.797 | 2.413 | 12.706 |
| Net Income
| 1,285.2 | 764.486 | 1,932.858 | 1,663.255 | 1,588.114 | 1,439.018 | 1,170.434 | 966.927 | 621.692 | 413.09 | 198.463 | 166.783 | 58.33 | 51.922 | 38.787 | 17.901 | 23.453 | -432.86 | -840.205 | -59.51 | -18.735 | 52.62 | 13.664 | -20.751 | 102.007 |
| Net Income Ratio
| 0.071 | 0.053 | 0.101 | 0.112 | 0.111 | 0.128 | 0.14 | 0.148 | 0.168 | 0.154 | 0.142 | 0.163 | 0.071 | 0.065 | 0.066 | 0.046 | 0.07 | -3.938 | -0.98 | -0.075 | -0.025 | 0.068 | 0.016 | -0.024 | 0.121 |
| EPS
| 0.26 | 0.15 | 0.38 | 0.33 | 0.32 | 0.3 | 0.26 | 0.22 | 0.17 | 0.16 | 0.097 | 0.095 | 0.033 | 0.03 | 0.025 | 0.022 | 0.01 | -0.52 | -1.01 | -0.072 | -0.023 | 0.064 | 0.016 | -0.025 | 0.12 |
| EPS Diluted
| 0.26 | 0.15 | 0.38 | 0.33 | 0.32 | 0.3 | 0.26 | 0.22 | 0.17 | 0.16 | 0.097 | 0.095 | 0.033 | 0.03 | 0.025 | 0.022 | 0.009 | -0.52 | -1.01 | -0.072 | -0.023 | 0.064 | 0.016 | -0.025 | 0.12 |
| EBITDA
| 2,553.265 | 2,313.054 | 3,596.765 | 3,211.923 | 3,041.703 | 2,584.399 | 2,193.278 | 1,772.003 | 912.824 | 665.549 | 332.309 | 271.311 | 128.886 | 147.669 | 130.27 | 79.245 | 59.845 | 88.609 | -761.162 | 51.298 | 120.469 | 236.653 | 91.463 | 51.232 | 220.003 |
| EBITDA Ratio
| 0.141 | 0.162 | 0.189 | 0.217 | 0.212 | 0.23 | 0.263 | 0.271 | 0.246 | 0.247 | 0.238 | 0.266 | 0.157 | 0.184 | 0.221 | 0.203 | 0.18 | 0.806 | -0.887 | 0.065 | 0.158 | 0.304 | 0.109 | 0.06 | 0.261 |